Cite

    Davis, L. et al. (2020). Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence. Nuclear medicine communications. 41 (6), p. . [Online].